News

Health Canada Has Approved ZEPOSIA® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

Health Canada Has Approved ZEPOSIA® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

 3 4 5 6 7 8 9 10 11 12 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest